These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Current classifications of dystonies, treatment strategy]. Zalialova ZA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):85-9. PubMed ID: 23612417 [No Abstract] [Full Text] [Related]
23. The clinical syndrome of primary tic disorder associated with dystonia: a large clinical series and a review of the literature. Damásio J; Edwards MJ; Alonso-Canovas A; Schwingenschuh P; Kägi G; Bhatia KP Mov Disord; 2011 Mar; 26(4):679-84. PubMed ID: 21506147 [TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin. Bell MS; Vermeulen LC; Sperling KB Pharmacotherapy; 2000 Sep; 20(9):1079-91. PubMed ID: 10999501 [TBL] [Abstract][Full Text] [Related]
26. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia. Black KJ; Racette B; Perlmutter JS Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560 [No Abstract] [Full Text] [Related]
27. A decade of botulinum toxin injections for achalasia: where do we stand? Hoogerwerf WA; Pasricha PJ Endoscopy; 2002 Jul; 34(7):580-1. PubMed ID: 12170414 [No Abstract] [Full Text] [Related]
30. Movement, visceral and autonomic disorders: use of botulinum toxin. Moore AP Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755 [TBL] [Abstract][Full Text] [Related]
31. Jaw-opening dystonia: Quality of life after botulinum toxin injections. Charous SJ; Comella CL; Fan W Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222 [TBL] [Abstract][Full Text] [Related]
35. [Dystonia: their epidemiology, aetiology, diagnosis and treatment]. Rodríguez-Constela I; Rodríguez-Regal A; Cebrián-Pérez EM Rev Neurol; 2009 Jan; 48 Suppl 1():S61-9. PubMed ID: 19222018 [TBL] [Abstract][Full Text] [Related]
36. Cosmetic botulinum toxin injections. Carter SR; Seiff SR Int Ophthalmol Clin; 1997; 37(3):69-79. PubMed ID: 9279643 [No Abstract] [Full Text] [Related]
37. [Botulinum toxin in the treatment of spasticity]. Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066 [No Abstract] [Full Text] [Related]